Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers

Bohnenkamp H, Coleman J, Burchell J, Taylor-Papadimitriou J, Noll T (2004)
Cellular Immunology 231(1-2): 112-125.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
Cellular Immunology
Band
231
Zeitschriftennummer
1-2
Seite
112-125
ISSN
PUB-ID

Zitieren

Bohnenkamp H, Coleman J, Burchell J, Taylor-Papadimitriou J, Noll T. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology. 2004;231(1-2):112-125.
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., & Noll, T. (2004). Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology, 231(1-2), 112-125. doi:10.1016/j.cellimm.2004.12.007
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., and Noll, T. (2004). Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology 231, 112-125.
Bohnenkamp, H., et al., 2004. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology, 231(1-2), p 112-125.
H. Bohnenkamp, et al., “Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers”, Cellular Immunology, vol. 231, 2004, pp. 112-125.
Bohnenkamp, H., Coleman, J., Burchell, J., Taylor-Papadimitriou, J., Noll, T.: Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers. Cellular Immunology. 231, 112-125 (2004).
Bohnenkamp, H, Coleman, J, Burchell, J, Taylor-Papadimitriou, J, and Noll, Thomas. “Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1 specific cytotoxic T-cells identified by peptide-MHC-class-I tetramers”. Cellular Immunology 231.1-2 (2004): 112-125.

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Modern strategies and capabilities for activation of the immune response against tumor cells.
Sennikov SV, Khantakova JN, Kulikova EV, Obleukhova IA, Shevchenko JA., Tumour Biol 39(5), 2017
PMID: 28513301
Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C, Zhao H, Wang Y, Cai H, Xiao Y, Zeng Y, Chen H., HLA 88(6), 2016
PMID: 27679419
Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells.
Tanida T, Tanemura M, Miyoshi E, Nagano H, Furukawa K, Nonaka Y, Akita H, Hama N, Wada H, Kawamoto K, Kobayashi S, Eguchi H, Mori M, Doki Y., Int J Oncol 46(1), 2015
PMID: 25354268
Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.
Zhang P, Yi S, Li X, Liu R, Jiang H, Huang Z, Liu Y, Wu J, Huang Y., PLoS One 9(7), 2014
PMID: 25036145
MUC1 immunotherapy.
Beatson RE, Taylor-Papadimitriou J, Burchell JM., Immunotherapy 2(3), 2010
PMID: 20635898
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.
Grimshaw MJ, Papazisis K, Picco G, Bohnenkamp H, Noll T, Taylor-Papadimitriou J, Burchell J., Br J Cancer 98(4), 2008
PMID: 18253127
Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice.
Tian F, Wang L, Qin W, Wang F, Song B, Li Y, Wen W, Zhang Z, Zhu K, Zhang Q, Lee C, Zhong W, Guo Y, Wang H., Cancer Lett 271(2), 2008
PMID: 18675506
The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2.
Mitchell MS, Lund TA, Sewell AK, Marincola FM, Paul E, Schroder K, Wilson DB, Kan-Mitchell J., Cancer Immunol Immunother 56(3), 2007
PMID: 16874487
Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A., Cancer Immunol Immunother 56(10), 2007
PMID: 17503040
Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.
Saito H, Dubsky P, Dantin C, Finn OJ, Banchereau J, Palucka AK., Breast Cancer Res 8(6), 2006
PMID: 17129372

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 15919376
PubMed | Europe PMC

Suchen in

Google Scholar